Profile_bird

Hey there! Oncolytics is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving Oncolytics's tweets.

Already using Twitter
from your phone? Click here.

Oncolytics

  1. Oncolytics Announces Exercise of Underwriters’ Over-Allotment Option http://bit.ly/4TKKCH
  2. Oncolytics Closes US$12.75 Million Unit Offering http://bit.ly/5NZX9q
  3. Oncolytics Announces Terms of Unit Offering http://bit.ly/1GlTQ1
  4. Oncolytics Announces Unit Offering http://bit.ly/eMSHE
  5. Collaborators Present Positive Phase I/II Results in Advanced Solid Cancers with Focus on Head and Neck AACR-NCI-EORTC http://bit.ly/2nFVlx
  6. Collaborators Present Updated Phase I/II Results in Advanced Solid Cancers with Focus on Head and Neck AACR-NCI-EORTC http://bit.ly/4nUzxE
  7. Oncolytics Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting http://bit.ly/SDUMT
  8. Oncolytics Announces 2009 Third Quarter Results http://bit.ly/1iMBma
  9. Oncolytics Announces Results of Second Warrant Expiry Date Acceleration Program http://bit.ly/1yBj5g
  10. Oncolytics Collaborators to Present Phase II Sarcoma Trial Results at CTOS Annual Meeting http://bit.ly/2plz0l
  11. Oncolytics Announces Issuance of 33rd U.S. Patent http://bit.ly/1xDjFP
  12. Oncolytics to Present at BIO Investor Forum 2009 http://bit.ly/1YEA1A
  13. Oncolytics presenting at BioPartnering Europe http://bit.ly/Zdiug
  14. Oncolytics accelerates warrant expiry http://bit.ly/4tEFYE
  15. Oncolytics announces a SPA http://bit.ly/15pl8A
  16. Research supports Phase 2 trial - http://bit.ly/2zKBd
  17. U.S. Phase 2 melanoma trial begins http://bit.ly/TYMoY
  18. Oncolytics accelerates warrant expiry http://bit.ly/4iaUDh
  19. Webcast Sept. 10 at 10 a.m. ET -http://www.wsw.com/webcast/rrshq15/oncy
  20. REOLYSIN for KRAS mutated tumours http://www.newswise.com/articles/view/554679/